TENBORON

tenboron-logo

Tenboron is biochemically targeted radiation therapy. They offer services for boron neutron capture therapy designed to treat locally invasive malignant tumors.

#SimilarOrganizations #People #Financial #Website #More

TENBORON

Industry:
Biotechnology Health Care

Founded:
2010-01-01

Address:
Helsinki, Southern Finland, Finland

Country:
Finland

Website Url:
http://www.tenboron.fi

Total Employee:
1+

Status:
Active

Total Funding:
4.5 M EUR

Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro Apple Mobile Web Clips Icon Google Font API Google Tag Manager WordPress Google Analytics Global Site Tag Organization Schema


Similar Organizations

blue-belt-technologies-logo

Blue Belt Technologies

Blue Belt Technologies is a medical device company that focuses on technology and capabilities of surgical instrumentation.

cabaletta-bio-logo

Cabaletta Bio

Cabaletta Bio has adapted clinically-validated and FDA-approved CAR T cell technology to target B cell-mediated autoimmune diseases.

chimeron-bio-logo

Chimeron Bio

Chimeron Bio develops agents for personalized cancer gene therapy.

encoded-therapeutics-logo

Encoded Therapeutics

Encoded Therapeutics is a Harnessing the regulatory genome to create next-generation molecular therapies.

nodexus-logo

Nodexus

Nodexus is democratizing access to live single cells for applications including gene editing, drug development, and more.

obsidian-therapeutics-logo

Obsidian Therapeutics

Obsidian Therapeutics is a developer of a next-generation cell and gene therapies created to extend adoptive immunotherapy.

semma-therapeutics-logo

Semma Therapeutics

Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.

trevarx-biomedical-logo

Trevarx Biomedical

Trevarx Biomedical is a biomedical startup that develops new radiopharmaceuticals.

verismo-therapeutics-logo

Verismo Therapeutics

Verismo Therapeutics develops novel chimeric antigen receptors (CARs) that enhance T-cell-based cellular immunotherapy for cancer.

Current Employees Featured

erkki-tenhunen_image

Erkki Tenhunen
Erkki Tenhunen Co-Founder @ Tenboron
Co-Founder

Founder


erkki-tenhunen_image

Erkki Tenhunen

Investors List

innovestor_image

Innovestor

Innovestor investment in Series A - Tenboron

Official Site Inspections

http://www.tenboron.fi

  • Host name: 55067-63133.cloudwaysapps.com
  • IP address: 139.59.154.225
  • Location: Frankfurt am Main Germany
  • Latitude: 50.1188
  • Longitude: 8.6843
  • Timezone: Europe/Berlin
  • Postal: 60313

Loading ...

More informations about "Tenboron"

About us - TENBORON

About us Tenboron was founded in 2010 and started operation in late 2011. The inspiration came from the successful BNCT trials conducted at the Helsinki University Central Hospital and the โ€ฆSee details»

News - TENBORON

Mar 8, 2024 The Finnish Medicines Agency Fimea has approved Tenboronโ€™s Phase I clinical trial application. The study will be conducted at the Helsinki University Hospital.See details»

Tenboron - Crunchbase Company Profile & Funding

Tenboron is the developer of a boron neutron capture therapy intended to treat locally invasive malignant tumors.See details»

Tenboron Oy - LinkedIn

Tenboron Oy is a biotechnology company based in Finland. Our reason for being is to develop better boron carriers for Boron Neutron Capture Therapy (BNCT).See details»

Rahoituskierros täyttyi muutamassa tunnissa - Springvest

Koska syöpä on maailman toiseksi yleisin kuolinsyy, tällä olisi merkittävä yhteiskunnallinen vaikutus, niin terveydellisesti kuin taloudellisestikin. Springvest järjesti kasvuyhtiölle โ€ฆSee details»

Post - FIB

Oct 25, 2024 In 2010, a Finnish company, Tenboron, took on this challenge and began working on a better solution. As a result of the company's research and development, a patented boron โ€ฆSee details»

Suomalaisyhtiö Tenboron kehittää mullistavaa syöpähoitoa

Tenboron päässee kokeilemaan Suomessa kehitettyä ja valmistettua kantajamolekyyliään ensimmäistä kertaa BNCT-hoidossa vuonna 2025. Parhaassa tapauksessa se voi viedä โ€ฆSee details»

Tenboron Company Profile - Office Locations, Competitors ... - Craft

See insights on Tenboron including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»

Tenboron Ltd signs an agreement with Biovian for GMP contract ...

The agreement covers technical transfer, analytical method validation and GMP manufacturing of boron carriers at Biovianโ€™s facility in Turku, Finland. Aseptic filling and stability studies are also โ€ฆSee details»

Pipeline - TENBORON

Tenboronโ€™s lead boron carrier has a high number of boron atoms and an antibody targeting unit that directs the carrier specifically to cancerous cellsSee details»

Tenboron Oy on LinkedIn: News - TENBORON

Tenboron Oy 89 followers 2d We've had a slow start, but now the first patient has enrolled in the phase I clinical study. https://tenboron.fi/news/See details»

Tenboron 2025 Company Profile: Valuation, Funding & Investors

Information on valuation, funding, cap tables, investors, and executives for Tenboron. Use the PitchBook Platform to explore the full profile.See details»

Tenboron closed a funding round of โ‚ฌ1.5M - Nordic 9

Apr 23, 2019 Tenboron, a Helsinki, Finland-based pharmaceutical company, announced the completion of a new funding round totalling โ‚ฌ1.5M ($1.7M). The rounds investors were led by โ€ฆSee details»

Finnish Company Tenboron Develops Groundbreaking Cancer โ€ฆ

Mar 6, 2024 In 2010, a Finnish company, Tenboron, took on this challenge and began working on a better solution. As a result of the company's research and development, a patented boron โ€ฆSee details»

Tenboron - Overview, News & Similar companies | ZoomInfo.com

View Tenboron (www.tenboron.fi) location in Uusimaa, Finland , revenue, industry and description. Find related and similar companies as well as employees by title and much more.See details»

Tenboron & Medfiles: working together in cancer drug development

Apr 15, 2024 Tenboron is a biopharma company developing boron carrier substances, and has worked with Medfiles in cancer drug development since 2015.See details»

Tenboron Oy on LinkedIn: Finnish Company Tenboron Develops ...

Patient recruitment starts for Phase I clinical trial Study preparations have been completed and necessary permits obtained. Data from the first patient (s) expected in Q1/2024. Tenboron Oy โ€ฆSee details»

Privacy policy - TENBORON

PRIVACY POLICY GeneralIn order to give you the best possible service, we may need to collect and process certain personal data about you. However, we respect and value your privacy and โ€ฆSee details»

Tenboron Company Information - Funding, Investors, and More

Get information on funding, investors, industries, and more for Tenboron. See Tenboron company profile and funding data.See details»

linkstock.net © 2022. All rights reserved